Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Unmanipulated haploidentical peripheral blood stem cell transplantation for patients with Philadelphia-negative acute lymphoblastic leukaemia in first complete remission.

Wang F, Liu T, Wang L, Gu Z, Yang N, Luo L, Zhu C, Li M, Liu D, Gao C.

Leuk Lymphoma. 2019 Sep 13:1-10. doi: 10.1080/10428194.2019.1660965. [Epub ahead of print]

PMID:
31519118
2.

Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.

Mo XD, Xu LP, Zhang XH, Liu DH, Wang Y, Chen H, Yan CH, Chen YH, Han W, Wang FR, Wang JZ, Liu KY, Huang XJ.

Int J Cancer. 2015 Apr 1;136(7):1697-707. doi: 10.1002/ijc.29146. Epub 2014 Sep 2.

3.

Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.

Xue YJ, Cheng YF, Lu AD, Wang Y, Zuo YX, Yan CH, Wu J, Sun YQ, Suo P, Chen YH, Chen H, Jia YP, Liu KY, Han W, Xu LP, Zhang LP, Huang XJ.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1611-1620. doi: 10.1016/j.bbmt.2018.12.007. Epub 2018 Dec 8.

PMID:
30537550
4.

Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission.

Yan CH, Jiang Q, Wang J, Xu LP, Liu DH, Jiang H, Chen H, Zhang XH, Liu KY, Huang XJ.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1314-21. doi: 10.1016/j.bbmt.2014.04.011. Epub 2014 Apr 18.

5.

Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.

Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK, Morris LE, Bashey A.

Biol Blood Marrow Transplant. 2015 Jul;21(7):1299-307. doi: 10.1016/j.bbmt.2015.03.003. Epub 2015 Mar 19.

6.

Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.

Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Huang XJ.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1110-6. doi: 10.1016/j.bbmt.2015.02.009. Epub 2015 Feb 16.

7.

Haploidentical, Unmanipulated Granulocyte Colony-Stimulating Factor (G-CSF)-Primed Peripheral Blood Stem Cell Transplants for Acute Myeloid Leukemia (AML) in Remission: A Single Center Experience.

Luo L, Fang S, Zhao S, Li F, Zhou Y, Guan L, Yang N, Gu Z, Lin T, Wang F, Zhu C, Huang W, Liu D, Gao C.

Ann Transplant. 2019 Jun 21;24:367-373. doi: 10.12659/AOT.915182.

8.

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.

Santoro N, Ruggeri A, Labopin M, Bacigalupo A, Ciceri F, Gülbaş Z, Huang H, Afanasyev B, Arcese W, Wu D, Koc Y, Tischer J, Santarone S, Giebel S, Mohty M, Nagler A.

J Hematol Oncol. 2017 May 30;10(1):113. doi: 10.1186/s13045-017-0480-5.

9.

Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Gu B, Wu X, Chen G, Ma X, Jin Z, Tang X, Han Y, Fu C, Qiu H, Sun A, Wu D.

Leuk Res. 2017 Aug;59:41-46. doi: 10.1016/j.leukres.2017.05.013. Epub 2017 May 16.

PMID:
28549237
10.

[Comparison of immune reconstitution at early stage after unmanipulated haploidentical stem cell transplantation between high- and standard- risk Philadelphia chromosome- negative acute lymphoblastic leukemia patients in CR1].

Bian ZL, Chang YJ, Xu LP, Wang Y, Zhang XH, Liu KY, Huang XJ.

Zhonghua Xue Ye Xue Za Zhi. 2016 Aug 14;37(8):650-5. doi: 10.3760/cma.j.issn.0253-2727.2016.08.004. Chinese.

PMID:
27587244
11.

Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia.

Mo XD, Tang BL, Zhang XH, Zheng CC, Xu LP, Zhu XY, Wang Y, Liu HL, Yan CH, Chu XD, Chen H, Geng LQ, Liu KY, Sun ZM, Huang XJ.

Int J Cancer. 2016 Nov 1;139(9):2106-15. doi: 10.1002/ijc.30249. Epub 2016 Jul 15.

12.

Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study.

Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, Wu MQ, Wu DP, Huang XJ.

Clin Cancer Res. 2016 Jul 15;22(14):3467-76. doi: 10.1158/1078-0432.CCR-15-2335. Epub 2016 Feb 29.

13.

Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Wang J, Jiang Q, Xu LP, Zhang XH, Chen H, Qin YZ, Ruan GR, Jiang H, Jia JS, Zhao T, Liu KY, Jiang B, Huang XJ.

Biol Blood Marrow Transplant. 2018 Apr;24(4):741-750. doi: 10.1016/j.bbmt.2017.12.777. Epub 2017 Dec 13.

14.

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT.

Piemontese S, Boumendil A, Labopin M, Schmid C, Ciceri F, Arcese W, Koc Y, Gulbas Z, Tischer J, Bruno B, Wu D, Blaise D, Beelen D, Irrera G, Ruggeri A, Houhou M, Mohty M, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

J Hematol Oncol. 2019 Jul 4;12(1):68. doi: 10.1186/s13045-019-0751-4.

15.

Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission.

Chen J, Yang L, Fan Y, Xu Y, Han Y, Tang X, Qiu H, Fu C, Miao M, Chen F, Wu D.

Biol Blood Marrow Transplant. 2018 Apr;24(4):779-788. doi: 10.1016/j.bbmt.2017.12.796. Epub 2017 Dec 28.

16.

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT.

Shem-Tov N, Peczynski C, Labopin M, Itälä-Remes M, Blaise D, Labussière-Wallet H, Socié G, Kröger N, Mielke S, Afanasyev B, Chevallier P, Tischer J, Helbig G, Jindra P, Peric Z, Giebel S, Mohty M, Nagler A.

Leukemia. 2019 Aug 19. doi: 10.1038/s41375-019-0544-3. [Epub ahead of print]

PMID:
31427719
17.

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.

Gao XN, Lin J, Wang SH, Huang WR, Li F, Li HH, Chen J, Wang LJ, Gao CJ, Yu L, Liu DH.

Ann Hematol. 2019 Jan;98(1):185-193. doi: 10.1007/s00277-018-3482-7. Epub 2018 Aug 24.

18.

Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China.

Gao L, Zhang C, Gao L, Liu Y, Su Y, Wang S, Li B, Yang T, Yuan Z, Zhang X.

J Hematol Oncol. 2015 Jul 26;8:90. doi: 10.1186/s13045-015-0186-5.

19.

T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).

Sestili S, Labopin M, Ruggeri A, Velardi A, Ciceri F, Maertens J, Kanz L, Aversa F, Lewalle P, Bunjes D, Mohty M, Nagler A.

Cancer. 2018 May 15;124(10):2142-2150. doi: 10.1002/cncr.31310. Epub 2018 Feb 22.

20.

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

Dou LP, Li HH, Wang L, Li F, Huang WR, Yu L, Liu DH.

Chin Med J (Engl). 2018 Apr 5;131(7):790-798. doi: 10.4103/0366-6999.228243.

Supplemental Content

Support Center